Thrivent Financial for Lutherans
ACH

Thrivent Financial for Lutherans’s Accendra Health ACH Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,999
Closed -$491K – 2544
2025
Q2 		$491K Sell
53,999
-288
-0.5% -$2.12K ﹤0.01% 2159
2025
Q1 		$490K Sell
54,287
-2,840
-5% -$30K ﹤0.01% 2081
2024
Q4 		$747K Sell
57,127
-902
-2% -$12K ﹤0.01% 2056
2024
Q3 		$910K Sell
58,029
-2,819
-5% -$42.7K ﹤0.01% 1969
2024
Q2 		$821K Sell
60,848
-5,518
-8% -$113K ﹤0.01% 1974
2024
Q1 		$1.84M Sell
66,366
-1,802
-3% -$40K ﹤0.01% 1480
2023
Q4 		$1.31M Sell
68,168
-1,842
-3% -$33.4K ﹤0.01% 1667
2023
Q3 		$1.13M Sell
70,010
-2,891
-4% -$51.3K ﹤0.01% 1663
2023
Q2 		$1.39M Sell
72,901
-2,648
-4% -$47.2K ﹤0.01% 1589
2023
Q1 		$1.1M Sell
75,549
-2,648
-3% -$47.4K ﹤0.01% 1724
2022
Q4 		$1.53M Sell
78,197
-622
-0.8% -$12.1K ﹤0.01% 1448
2022
Q3 		$1.9M Buy
78,819
+4,045
+5% +$125K 0.01% 1250
2022
Q2 		$2.35M Buy
74,774
+13,347
+22% +$483K 0.01% 1139
2022
Q1 		$2.7M Buy
61,427
+20
+0% +$859 0.01% 1154
2021
Q4 		$2.67M Buy
61,407
+410
+0.7% +$16.1K 0.01% 1205
2021
Q3 		$1.91M Sell
60,997
-436
-0.7% -$17.2K ﹤0.01% 1383
2021
Q2 		$2.6M Sell
61,433
-8,661
-12% -$337K 0.01% 1251
2021
Q1 		$2.63M Buy
70,094
+9,246
+15% +$289K 0.01% 1231
2020
Q4 		$1.65M Buy
60,848
+7,962
+15% +$205K ﹤0.01% 1442
2020
Q3 		$1.33M Buy
52,886
+210
+0.4% +$3.06K ﹤0.01% 1401
2020
Q2 		$401K Hold
52,676
– – ﹤0.01% 2005
2020
Q1 		$482K Buy
52,676
+2,630
+5% +$15.9K ﹤0.01% 1733
2019
Q4 		$259K Buy
50,046
+34
+0.1% +$218 ﹤0.01% 2103
2019
Q3 		$291K Buy
50,012
+1,161
+2% +$5.21K ﹤0.01% 2046
2019
Q2 		$156K Buy
48,851
+1,339
+3% +$4.57K ﹤0.01% 2155
2019
Q1 		$195K Buy
47,512
+3,413
+8% +$21.6K ﹤0.01% 2110
2018
Q4 		$279K Buy
44,099
+969
+2% +$10.1K ﹤0.01% 1829
2018
Q3 		$713K Buy
43,130
+741
+2% +$12.6K ﹤0.01% 1488
2018
Q2 		$708K Buy
42,389
+1,770
+4% +$28.7K ﹤0.01% 1483
2018
Q1 		$632K Buy
40,619
+27,030
+199% +$482K ﹤0.01% 1503
2017
Q4 		$257K Buy
13,589
+519
+4% +$11.5K ﹤0.01% 1930
2017
Q3 		$382K Buy
13,070
+700
+6% +$20.7K ﹤0.01% 1690
2017
Q2 		$398K Buy
12,370
+1,010
+9% +$33.1K ﹤0.01% 1635
2017
Q1 		$393K Buy
11,360
+830
+8% +$29.6K ﹤0.01% 1643
2016
Q4 		$372K Buy
10,530
+770
+8% +$26K ﹤0.01% 1630
2016
Q3 		$339K Buy
9,760
+780
+9% +$27.3K ﹤0.01% 1647
2016
Q2 		$336K Buy
8,980
+920
+11% +$34.6K ﹤0.01% 1614
2016
Q1 		$326K Buy
8,060
+810
+11% +$30.2K ﹤0.01% 1571
2015
Q4 		$261K Buy
7,250
+250
+4% +$9.04K ﹤0.01% 1644
2015
Q3 		$224K Buy
7,000
+500
+8% +$17K ﹤0.01% 1569
2015
Q2 		$221K Buy
+6,500
New +$219K ﹤0.01% 1573

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans's ACH Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 53,999 shares — an estimated $491K sold.

Thrivent Financial for Lutherans first reported a position in ACH in Q2 2015 and held it in 41 quarters. The position peaked at $2.7M in Q1 2022. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 53,999 Accendra Health shares in Q3 2025, an estimated $491K.
  • Thrivent Financial for Lutherans first reported a position in Accendra Health in Q2 2015 and held it in 41 quarters.
  • Thrivent Financial for Lutherans's Accendra Health position peaked at $2.7M in Q1 2022.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.